Evidence map›Paper›PMID 35223481›Full record

ArticleFrontiers in oncology2022

Robot-Assisted Totally Intracorporeal Resection of Cutaneous Ureterostomy Tumor and Ileal Conduit Surgery: A Rare Case Report.

Lingkai Cai, Juntao Zhuang, Qiang Cao, Baorui Yuan, Qikai Wu, Kai Li, Jie Han, Hao Yu, JianCheng Lv, Dexiang Feng and 5 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Lingkai CaiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Juntao ZhuangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qiang CaoDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Baorui YuanDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qikai WuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kai LiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jie HanDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hao YuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
JianCheng LvDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Dexiang FengDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Peikun LiuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ruixi YuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pengchao LiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiao YangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qiang LuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadical cystectomy (RC) is the standard treatment for muscular invasive bladder cancer (MIBC) and some high-risk non-muscular invasive bladder cancer (NMIBC). Cutaneous ureterostomy is a common form of urinary diversion. However, after radical cystectomy, recurrence of upper urinary tract malignancies is possible. There is no relevant report on how to improve this situation's management. CASE PRESENTATION: This case is a 56-year-old male patient hospitalized due to the development of a new tumor in the ureteral cutaneous stoma following radical cystectomy for more than five years. A biopsy of the tumor revealed high-grade urothelial carcinoma. Computed tomography (CT) revealed that the local soft tissue around the cutaneous stoma was thickened, but no other lesions were visible. After evaluating the case, we chose robot-assisted completely intracorporeal resection of cutaneous ureterostomy tumor and ileal conduit surgery. The total time for the operation and the blood loss were 400 minutes and 150 ml, respectively. Following surgery, the patient got standard chemotherapy in combination with immunotherapy. Additionally, ten months following the surgery, the patient did not experience disease progression or complications.

conclusionThe robot-assisted operation is safe and feasible for upper urinary tract tumor recurrence following radical cystectomy with cutaneous ureterostomy.

Indexed as

BCacutaneous ureterostomyileal conduitrecurrencerobot

Identifiers

PMID35223481
PMCPMC8867703
OpenAlexW4210971548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.